Penserra Capital Management LLC Boosts Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Penserra Capital Management LLC lifted its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 147.6% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 3,320 shares of the company's stock after purchasing an additional 1,979 shares during the period. Penserra Capital Management LLC's holdings in HCA Healthcare were worth $1,146,000 at the end of the most recent quarter.

Several other hedge funds have also recently modified their holdings of HCA. Congress Wealth Management LLC DE increased its stake in HCA Healthcare by 3.4% during the 4th quarter. Congress Wealth Management LLC DE now owns 1,039 shares of the company's stock valued at $312,000 after purchasing an additional 34 shares in the last quarter. Perigon Wealth Management LLC lifted its stake in shares of HCA Healthcare by 2.3% in the 1st quarter. Perigon Wealth Management LLC now owns 1,797 shares of the company's stock valued at $621,000 after purchasing an additional 40 shares during the period. Whittier Trust Co. lifted its stake in shares of HCA Healthcare by 3.6% in the 4th quarter. Whittier Trust Co. now owns 1,195 shares of the company's stock valued at $359,000 after purchasing an additional 41 shares during the period. Barden Capital Management Inc. increased its holdings in HCA Healthcare by 1.4% in the 1st quarter. Barden Capital Management Inc. now owns 2,921 shares of the company's stock worth $1,009,000 after acquiring an additional 41 shares in the last quarter. Finally, Coldstream Capital Management Inc. increased its holdings in HCA Healthcare by 1.3% in the 4th quarter. Coldstream Capital Management Inc. now owns 3,471 shares of the company's stock worth $1,042,000 after acquiring an additional 44 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company's stock.

HCA Healthcare Price Performance

HCA Healthcare stock traded down $2.56 during midday trading on Friday, reaching $375.76. The company's stock had a trading volume of 877,096 shares, compared to its average volume of 1,460,285. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $417.14. The company has a debt-to-equity ratio of 69.07, a quick ratio of 1.06 and a current ratio of 1.19. The stock's 50 day simple moving average is $374.58 and its 200 day simple moving average is $341.23. The firm has a market capitalization of $90.40 billion, a PE ratio of 16.71, a P/E/G ratio of 1.31 and a beta of 1.47.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its earnings results on Friday, April 25th. The company reported $6.45 EPS for the quarter, beating analysts' consensus estimates of $5.75 by $0.70. HCA Healthcare had a return on equity of 1,063.91% and a net margin of 8.07%. The company had revenue of $18.32 billion during the quarter, compared to the consensus estimate of $18.26 billion. During the same quarter last year, the company earned $5.36 earnings per share. HCA Healthcare's quarterly revenue was up 5.7% compared to the same quarter last year. On average, equities research analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, June 30th. Stockholders of record on Monday, June 16th were given a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.77%. The ex-dividend date was Monday, June 16th. HCA Healthcare's dividend payout ratio is currently 12.81%.

Wall Street Analyst Weigh In

HCA has been the subject of a number of research reports. Royal Bank Of Canada reaffirmed an "outperform" rating and set a $404.00 target price (up previously from $376.00) on shares of HCA Healthcare in a report on Monday, June 23rd. Wells Fargo & Company raised shares of HCA Healthcare from an "underweight" rating to an "equal weight" rating and upped their target price for the company from $320.00 to $385.00 in a research report on Thursday, May 29th. Barclays set a $416.00 target price on shares of HCA Healthcare and gave the company an "overweight" rating in a research report on Monday, June 2nd. Wall Street Zen raised shares of HCA Healthcare from a "hold" rating to a "buy" rating in a research report on Saturday, July 5th. Finally, Guggenheim started coverage on shares of HCA Healthcare in a research note on Wednesday, April 9th. They set a "neutral" rating on the stock. Seven equities research analysts have rated the stock with a hold rating, eleven have given a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $395.71.

Insider Buying and Selling

In related news, COO Jon M. Foster sold 15,698 shares of HCA Healthcare stock in a transaction dated Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the completion of the sale, the chief operating officer owned 12,646 shares in the company, valued at approximately $4,670,420.72. This trade represents a 55.38% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 1.30% of the company's stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.